[Research progress on neurodevelopmental disorders associated with congenital heart disease]

Yu-Mei Liu1, Tian-Yu Liu, Shao-Han Nong1

  • 1Department of Neonatology, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China.

Insights

Children with congenital heart disease (CHD) have a high risk of neurodevelopmental disorders. This review explores their characteristics to guide early, preventive interventions for better child health outcomes.

Area of Science:

  • Pediatrics
  • Neurodevelopmental Disorders
  • Congenital Heart Disease

Background:

  • Neurodevelopmental disorders (NDDs) present a significant global public health challenge in children.
  • Children with congenital heart disease (CHD) exhibit a notably higher incidence of NDDs.
  • NDD characteristics in CHD patients are influenced by CHD type, surgical interventions, age, and comorbidities.

Purpose of the Study:

  • To review the clinical characteristics of NDDs in children with CHD.
  • To establish a theoretical foundation for novel preventive early intervention strategies.
  • To reduce the incidence of NDDs in the CHD population.

Main Methods:

  • Literature review focusing on clinical characteristics of NDDs in CHD.
  • Analysis of factors influencing NDD presentation in CHD patients.
  • Synthesis of findings to inform intervention models.

Main Results:

  • Detailed review of clinical features of NDDs associated with various CHD types.
  • Identification of specific risk factors and influencing variables.
  • Summary of promising results from international early intervention studies.

Conclusions:

  • Understanding NDD characteristics in CHD is crucial for targeted interventions.
  • Early diagnosis and treatment models show promise for high-risk children.
  • This review provides a basis for implementing new preventive techniques to improve neurodevelopmental outcomes in CHD patients.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...